Benchmarking Synthetic Data Solutions: A Technical Comparison
The demand for privacy-preserving, scalable data has pushed synthetic data solutions to the forefront of AI development. Data engineers must juggle…
Read more →Guardant Health’s GuardantINFORM platform combines de-identified longitudinal clinical and genomic data from more than 207,000 patients tested with its Guardant360 liquid-biopsy assay, used by biopharma for clinical-trial design and post-marketing research. Guardant Health is publicly traded (Nasdaq: GH).
Tabular